I just came back from my appt at MS Clinic in Worcester. She talked to me about Lemtrada. It is currently being used in Europe and Australia with great results for both remitting relapsing MS and Secondary Progressive. FDA had rejected it previously because not enough long term data, but they are reviewing it again with a decision expected in November. She feels confident enough about it that she sent me for MRI.
What does anyone know about this? I guess my heart condition is not an issue.
~Susan
What does anyone know about this? I guess my heart condition is not an issue.
~Susan


Comment